Swarm Oncology announces Martin Olin as Chief Executive Officer - Swarm Oncology Swarm Oncology Unveils Highly Differentiated, Personalised T Cell Therapy Platform to Significantly Improve Treatment Outcome for Cancer Patients and Appoints Martin Olin as Chief Executive Officer

Officially launched (a few weeks ago)! It has been an exciting time working on this novel T cell therapy project for the past year with the aim to address a significant unmet need in solid cancer treatments #tcelltherapy #cancerresearch
swarmoncology.bio/swarm-oncolo...

Eosinophils promote monocyte to macrophage differentiation and anti-bacterial immunity Chemokine receptors control cell migration within the body. Here we reveal a novel interaction between eosinophils and monocytes in the bone marrow, indirectly controlled by the atypical chemokine rec...

Our new preprint is here! We show eosinophils are retained in the bone marrow by everyone’s (our😊) favourite atypical #chemokine receptor ACKR2.
#Eosinophil education of #monocytes promotes differentiation to #macrophages and bacterial elimination during E.coli #infection. Please read and share.